ABSTRACT
AIMS: The manufacturing processes have been reported to influence the properties of probiotics with potential impact on health properties. The aim was to investigate the effect of different growth media and inactivation methods on the properties of canine-originated probiotic bacteria alone and in combination mixture. METHODS AND RESULTS: Three established dog probiotics, Lactobacillus fermentum VET9A, Lactobacillus plantarum VET14A and Lactobacillus rhamnosus VET16A, and their combination mixture were evaluated for their adhesion to dog mucus. The effect of different growth media, one reflecting laboratory and the other manufacturing conditions, and inactivation methods (95°C, 80°C and UV irradiation) on the mucus adhesion of the probiotic strains was characterized. Evaluation of dog probiotics was supported by cell visualization using transmission electron microscopy (TEM). Higher adhesion percentage was reported for probiotic strains growing in laboratory rather than in manufacturing conditions (P < 0.05). Inactivation by heat (95°C, 80°C) decreased the adhesion properties when strains were cultivated in soy-based growth media compared with those grown in MRS broth (P < 0.05). TEM observations uncovered differences in cell-surface components in nonviable forms of probiotic strains as compared with their viable forms. CONCLUSIONS: Manufacturing process conditions such as growth media and pretreatment methods may significantly affect the adhesive ability of the tested strains. SIGNIFICANCE AND IMPACT OF THE STUDY: Growth conditions, growth media, pretreatment methods and different probiotic combinations should be carefully considered for quality control of existing probiotics and for identification of new probiotics for dogs. These may also have an impact on health benefits for the host.
Subject(s)
Bacterial Adhesion , Dogs/microbiology , Lactobacillus/physiology , Probiotics , Animals , Culture Media , Limosilactobacillus fermentum/growth & development , Limosilactobacillus fermentum/physiology , Lactobacillus plantarum/growth & development , Lactobacillus plantarum/physiology , Lacticaseibacillus rhamnosus/growth & development , Lacticaseibacillus rhamnosus/physiology , Mucus/microbiologyABSTRACT
The objective of this study was to evaluate growth and attachment of human gingival fibroblasts on nonresorbable sol-gel-derived nanoporous titania (TiO2) coated discs and noncoated commercially pure titania (cpTi) discs in vitro. The strength of attachment was evaluated using serial trypsinization. The number of cells detached from TiO2-substrates was 30% +/- 3%, whereas those detached from the cpTi was 58% +/- 4% indicating a stronger cell attachment on the coated surfaces. In scanning electron microscopy (SEM) images fewer cells, with more rounded shape, were seen with cpTi than with TiO2 after the detachment assay. Fibroblasts grew more efficiently on TiO2 than on cpTi substrates, showing significantly higher cell activities at all times. In transmission electron microscopy (TEM), a continuous layer of two to three cells thick covered the coated and noncoated discs after 7 days of culture. The plasma membrane of cells in contact with the coating was in close opposition and the cytoplasm was ultrastructurally similar to the cells grown on noncoated discs with well-preserved organelles. In conclusion, we demonstrated that the sol-gel-derived TiO2 coatings can facilitate cell growth and attachment of human gingival fibroblasts on titanium in vitro. This in vitro study is in line with our previous in vivo observations of improved soft tissue attachment of TiO2 coatings in comparison with cpTi.
Subject(s)
Coated Materials, Biocompatible/pharmacology , Fibroblasts/cytology , Fibroblasts/drug effects , Gels/pharmacology , Titanium/pharmacology , Cell Adhesion/drug effects , Cell Proliferation/drug effects , Cells, Cultured , DNA/metabolism , Fibroblasts/ultrastructure , HumansABSTRACT
This study was designed to examine the attachment and reactions of soft tissues to sol-gel-derived TiO2 coatings. In the first experiment, TiO2 coated and uncoated titanium cylinders were placed subcutaneously into the backs of rats for 3, 11 and 90 days. Tissue response and implant surfaces were characterized with routine light microscopy and scanning electron microscopic (SEM) analysis. In the second experiment, TiO2-coated and uncoated discs were implanted subcutaneously into the backs of rats for 14 and 21 days. The discs were pulled out from the implantation sites with a mechanical testing device using a constant speed of 5 mm/min. Rupture force was registered, after which the discs were assigned for SEM and transmission electron microscopic (TEM) analysis. All the coated implants showed immediate contact with the surrounding soft tissues without a clear connective tissue capsule. Significantly better soft tissue response was measured for all the coated compared to the uncoated cylinders (p<0.01). Higher rupture forces were measured for all coated discs, although the differences were not statistically significant. An immediate and tight connection between connective tissue fibroblasts and coatings was noticed in TEM analysis. Our study indicates that TiO2 coatings improve soft tissue attachment on a titanium surface.
Subject(s)
Coated Materials, Biocompatible/pharmacology , Connective Tissue/drug effects , Prostheses and Implants , Titanium/pharmacology , Animals , Cell Adhesion/drug effects , Coated Materials, Biocompatible/chemistry , Connective Tissue/anatomy & histology , Connective Tissue/physiology , Male , Materials Testing , Phase Transition , Rats , Rats, Long-Evans , Stress, Mechanical , Surface Properties , Titanium/chemistryABSTRACT
The effects of testosterone treatment on spermatogenesis in the rat have been investigated by morphometric and structural analysis at the ultrastructural level in stages VII-IX. The aim has been to characterize the changes in Sertoli and spermatogenic cells to elucidate the mechanism of testosterone effects on spermatogenesis and to test the possibilities of developing male contraceptives. In stage VII, the morphometric parameters of volume and surface area in Sertoli cells (see abbreviations below): and the morphometric parameter of volume in the spermatogenic cells such as V(VPG,T), V(VPC,T), V(VrPT,T) and V(VelPT,T) decreased. In stage VIII, the respective values of Sertoli cells, VSN, and VSN/VSC decreased while SSJ increased, and the respective morphometric parameters in the spermatogenic cells, V(VPG,T), V(VPC,T), and V(VrPT,T) increased. In stage IX, in Sertoli cells VSC, VSN, VSN/VSC, and SSJ remained unchanged. In spermatogenic cells V(VPG,T), V(VPC,T), and V(VrPT,T) increased. Further, in all stages, a close apposition of mitochondria and rough endoplasmic reticulum in basolateral cytoplasm of Sertoli cells suggested active protein synthesis. In elongated spermatids in stage IX the microtubular manchette became disorganized. This disorganization and the unexpected shift after testosterone treatment from decrease in several morphometric parameters in stage VIII to increases in stage IX cannot be explained by alterations in testosterone (T), LH, FSH, and their respective receptors. Therefore, still unknown regulatory factors in spermatogenesis are apparently involved in the developmental interactions between Sertoli and spermatogenic cells.
Subject(s)
Sertoli Cells/cytology , Sertoli Cells/physiology , Spermatogenesis , Animals , Cell Nucleus/ultrastructure , Epithelial Cells/cytology , Epithelial Cells/ultrastructure , Follicle Stimulating Hormone/analysis , Luteinizing Hormone/analysis , Male , Microscopy, Electron , Rats , Rats, Wistar , Seminiferous Tubules/cytology , Seminiferous Tubules/ultrastructure , Sertoli Cells/ultrastructure , Spermatids/cytology , Spermatids/ultrastructure , Spermatogonia/cytology , Spermatogonia/physiology , Spermatogonia/ultrastructure , Testosterone/analysis , Tight Junctions/ultrastructureABSTRACT
Five intraperitoneal injections of endothelin-1 (100 microg/kg) to newborn albino rats on days 2-6 of life did not change the number of nuclei expressing PCNA in the left-ventricular myocardium. The number of nucleoli, area and perimeter of cardiomyocytes (isolated by the method of alkaline dissociation) increased. The number of myocyte nuclei in the state of apoptosis (evaluated by the TUNEL method) increased significantly. Presumably, partial loss of cardiomyocytes as a result of apoptosis activation after treatment with endothelin-1 is compensated by increased size and transcription activity of remaining cardiomyocytes.
Subject(s)
Apoptosis/physiology , Cell Proliferation , Endothelin-1/pharmacology , Myocytes, Cardiac/drug effects , Proteins/metabolism , Animals , Animals, Newborn , Endothelin-1/administration & dosage , In Situ Nick-End Labeling , Myocytes, Cardiac/cytology , Myocytes, Cardiac/metabolism , Proliferating Cell Nuclear Antigen/metabolism , RatsABSTRACT
Excessive activation of excitatory amino acid receptors has been implicated in neuronal death in a number of central nervous system insults. We have here investigated, the time course and mechanisms of kainate (KA)- induced neuronal death in immature organotypic hippocampal slice cultures (OHCs) using Fluoro-Jade B (FJB) staining as a marker of cell death, and immunoblotting, immunocytochemistry, and electron microscopy as methods to clarify the mechanisms. After 6 KA treatment (5 microM), no significant neuronal death was detected in any hippocampal subregion, whereas the treatment of 12, 24, and 48 h resulted in neuronal death in the CA3 regions, but not in CA1. The 48 h resting period in normal medium after KA-treatment did not rescue the cells but further increased the number of dead neurons in CA3 as compared to the corresponding acute phase. In Western blotting, the expression levels of the active, 17 kDa form of caspase-3, and the 84-85 kDa cleaved fragment of poly(ADP ribose)polymerase (PARP) were not altered from the control levels. Moreover, no active caspase-3 labelled cells were detected in immunocytochemical study 24 h after KA treatment either in the acute or resting groups. Electron microscopy showed non-apoptotic injury in the CA3a/b pyramidal neurons in KA-treated slices. Our results suggest that KA-induced neuronal death in immature OHCs is a strictly region-specific, irreversible, necrotic process.
Subject(s)
Hippocampus/cytology , Hippocampus/drug effects , Kainic Acid/toxicity , Neurons/cytology , Neurons/drug effects , Animals , Cell Death/drug effects , Cell Death/physiology , Cell Differentiation/drug effects , Hippocampus/ultrastructure , Neurons/ultrastructure , Organ Culture Techniques , Organ Specificity/drug effects , Rats , Rats, WistarABSTRACT
Previous studies have shown that both halothane and isoflurane have adverse but reversible effects on alveolar physiology. The present study was designed to test the hypothesis that also sevoflurane may affect alveolar integrity. Fifteen pigs were randomly selected to receive either thiopentone infusion (control group, n=8) or sevoflurane (n=7) at 4.0% inspiratory concentration (1.5 MAC) in air for 6 h. Tissue samples from the lungs were obtained at the end of the experiment. Both histopathological light microscopy and electron microscopy were used to assess the structural integrity of the alveoli. Pulmonary hemodynamics were comparable in both groups. Light microscopy showed no difference between the groups in the amount of alveolar macrophages, red blood cells or edema. Electron microscopy showed minor changes such as moderate local swelling of alveolar epithelium in both study groups. Alveolar type II cells were ultrastructurally unaltered in both study groups. We conclude that long-term, high concentration exposure to sevoflurane has no detrimental effect on the alveolar integrity in pigs.
Subject(s)
Anesthetics, Inhalation/pharmacology , Methyl Ethers/pharmacology , Pulmonary Alveoli/drug effects , Anesthesia , Anesthetics, Inhalation/toxicity , Anesthetics, Intravenous/pharmacology , Animals , Epithelium/ultrastructure , Female , Hemodynamics/drug effects , Male , Methyl Ethers/toxicity , Microscopy, Electron , Pulmonary Alveoli/pathology , Pulmonary Alveoli/ultrastructure , Sevoflurane , Swine , Thiopental/toxicityABSTRACT
Human myeloma cell lines are difficult to establish, and they usually originate from patients with extramedullary disease. We describe a new human myeloma cell line, TU-1, which was established from the bone marrow of a patient without extramedullary myeloma. The myeloma cells were initially maintained in a conditioned medium derived from another well-known myeloma cell line U-266. This conditioned medium contained interleukin-6 (IL-6) and oncostatin M (OSM), and possibly other unknown growth factors as well. In 3 months the TU-1 cell line proliferated autonomously and secreted IL-6 and OSM with a synergistic growth response. As we have previously shown the cell line acquired a p53 mutation in vitro, which may be an important factor causing autonomous proliferation. In patients with multiple myeloma OSM is frequently found in the serum and OSM has been associated with serum IL-6 and progressive disease. Our study demonstrates the close relationship of OSM and IL-6 also in vitro.
Subject(s)
Autocrine Communication , Interleukin-6/pharmacology , Multiple Myeloma/metabolism , Peptides/pharmacology , Tumor Cells, Cultured/cytology , Cell Division/drug effects , Drug Synergism , Genes, Immunoglobulin/genetics , Genes, p16 , Humans , Immunophenotyping , Interleukin-6/biosynthesis , Male , Middle Aged , Multiple Myeloma/pathology , Oncostatin M , Peptides/metabolism , Sequence Deletion , Tumor Cells, Cultured/immunology , Tumor Cells, Cultured/metabolismABSTRACT
PURPOSE: To study the expression and distribution of transcription factor Sox9 and type IIA procollagen in the developing and aging eyes of normal and transgenic Dell mice carrying pro(alpha)1(II) collagen transgenes with a short deletion mutation, which cause ocular abnormalities in this mouse line. METHODS: The eyes of Del1 mice were studied on embryonic days E14.5, E16.5 and E18.5, and at the ages of 4 and nine months, using their nontransgenic littermates as controls. Sox9 and pro(alpha)1(IIA) collagen were detected by RNase protection assay and immunohistochemistry. RESULTS: RNase protection assay revealed Sox9 transcripts in the eyes of Del1 and control mice during development and aging. The mRNA for type IIA procollagen had a similar temporal expression pattern. On embryonic days E14.5, E16.5 and E18.5, Sox9 was located by immunohistochemistry in the nuclei and type IIA procollagen in the extracellular space of the developing retina. During growth and aging, the ocular expression of Sox9 mRNA and the immunohistochemical reaction for Sox9 antibody diminished, concomitant with the reduction in type II procollagen mRNA. However, at the age of nine months, levels of Sox9 and type IIA procollagen mRNAs were higher in the degenerating eyes of Del1 and control mice. CONCLUSIONS: The similarities in the temporo-spatial distribution of Sox9 and type IIA procollagen suggest that this transcription factor is involved in the activation of type II collagen expression in the eye, as has been demonstrated in prechondrogenic mesenchyme and immature cartilage. The increased production of Sox9 and type IIA procollagen in the aging retina and vitreous is analogous to degenerating articular cartilage where attempted tissue repair has also been observed.
Subject(s)
Aging/metabolism , Collagen Type II/genetics , High Mobility Group Proteins/metabolism , Mutation , Peptide Fragments/metabolism , Procollagen/metabolism , Retina/embryology , Transcription Factors/metabolism , Vitreous Body/embryology , Animals , Down-Regulation , High Mobility Group Proteins/genetics , Immunoenzyme Techniques , Male , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Mice, Transgenic , Peptide Fragments/genetics , Procollagen/genetics , RNA, Messenger/metabolism , Retina/growth & development , Retina/metabolism , SOX9 Transcription Factor , Transcription Factors/genetics , Vitreous Body/growth & development , Vitreous Body/metabolismABSTRACT
Among farm animals, two species present an intersex condition at a relatively high frequency: pig and goat. Both are known to contain XX sex-reversed individuals which are genetically female but with a true hermaphrodite or male phenotype. It has been clearly demonstrated that the SRY gene is not involved in these phenotypes. Consequently, autosomal or X-linked mutations in the sex-determining pathway may explain these sex-reversed phenotypes. A mutation referred to as "polled" has been characterized in goats by the suppression of horn formation and abnormal sexual differentiation. The Polled Intersex Syndrome locus (PIS) was initially located in the distal region of goat chromosome 1. The homologous human region has been precisely identified as an HSA 3q23 DNA segment containing the Blepharophimosis Ptosis Epicanthus locus (BPES), a syndrome combining Premature Ovarian Failure (POF) and an excess of epidermis of the eyelids. In order to isolate genes involved in pig intersexuality, a similar genetic approach was attempted in pigs using genome scanning of resource families. Genetic analyses suggest that pig intersexuality is controlled multigenically. Parallel to this work, gonads of fetal intersex animals have been studied during development by light and electron microscopy. The development of testicular tissue and reduction of germ cell number by apoptosis, which simultaneously occurs as soon as 50 days post coïtum, also suggests that several separate genes could be involved in pig intersexuality.
Subject(s)
Disorders of Sex Development/genetics , Goats/genetics , Sex Determination Processes , Swine/genetics , X Chromosome/genetics , Animals , Apoptosis , Female , Humans , Male , Microscopy , Microscopy, Electron , Phenotype , Testis/cytology , Testis/embryologyABSTRACT
In an attempt to understand the etiology of intersexuality in pigs, we thoroughly analyzed the gonads of 38,XX (SRY negative) female to male sex-reversed animals at different developmental stages: during fetal life [50 and 70 days postcoitum (dpc)], just after birth [35 days postpartum (dpp)] and during adulthood. For each animal studied, we performed parallel histological and ultrastructural analyses on one gonad and RT-PCR analysis on the other gonad in order to define the expression profiles of sexually regulated genes: SOX9, 3beta-HSD, P450 aromatase, AMH, FOXL2, and Wnt4. Light and electron microscopic examination showed that testicular cords differentiated in XX sex-reversed gonads but were hypoplastic. Although the testicular cords contained gonia at the fetal stages, the germ cells had all died through apoptosis within a few weeks after birth. Ultrastructurally normal Leydig cells also differentiated, but later, and enclosed whorl-like residual bodies. At the fetal stages, three of the six genes studied in the intersex gonads presented, as early as 50 dpc, a modified expression profile corresponding to an elevated expression of SOX9 and the beginning of AMH and P450 aromatase gene transcription. In addition to genes involved in the testicular pathway, the same gonads expressed FOXL2, an ovarian-specific factor. The ovaries of true hermaphrodites were ineffective in ensuring correct folliculogenesis and presented abnormal expression profiles of ovarian specific genes after birth. These results indicate that the genes involved in this pathology act very early during gonadogenesis and affect the ovary-differentiating pathway with variable expressivity from ovarian germ cell depletion through to trans-differentiation into testicular structures.
Subject(s)
Animals, Newborn/physiology , Disorders of Sex Development , Fetus/physiology , Swine/physiology , Animals , Disorders of Sex Development/embryology , Disorders of Sex Development/pathology , Embryonic and Fetal Development , Female , Genitalia/anatomy & histology , Genitalia/embryology , Gonads/anatomy & histology , Gonads/embryology , Gonads/metabolism , Male , Time FactorsABSTRACT
Early effects of testosterone (T) treatment on the ultrastructure of testicular interstitium were analyzed by morphometry. In T-treated young adult rats the T-LH feed-back loop functioned as expected and the marked increase in peripheral T caused almost complete depletion of peripheral LH. Even though the peripheral LH concentration was almost undetectably low, the Leydig cells maintained regulatory interactions with macrophages, peritubular myoid cells and with the seminiferous epithelium lining the tubular lumina as indicated by the high correlations of morphometric parameters between the Leydig and other cell types. The morphometric alterations in the ultrastructure of Leydig cells suggest that the seminiferous tubules may signal by releasing inhibitory paracrine factors affecting the morphology and function of Leydig cells in T-treated young adult rats. The morphometry of Leydig cells in T-treated young adult rats showed a significant quantifiable reduction in nuclei and organelles involved in steroid synthesis and this analysis also offers a good basis for elucidation of the early effects of testosterone in terms of its contraceptive function as well as of different toxic compounds on reproductive functions.
Subject(s)
Leydig Cells/drug effects , Testosterone/pharmacology , Animals , Leydig Cells/ultrastructure , Male , Microscopy, Electron/methods , Rats , Rats, Wistar , Testis/cytology , Testis/drug effects , Testis/ultrastructure , Testosterone/bloodABSTRACT
The manifestations of sex determination were studied in vivo by detection and localization of structural and regulatory macromolecules (type IV collagen alpha 1, alpha 2, alpha 3, alpha 4, and alpha 5; laminin alpha 5, beta 1, and beta 2; cytokeratins 18 and 19, desmin, vimentin; integrin alpha(6;) anti-Müllerian hormone (AMH); and SOX9 in developing male and female gonads by light and electron microscopy, immunocytochemistry, and protein analysis. The goal has been to find sex-related differences and on this basis to offer new molecules to be tested further for a possible role in sex determination. Specific antibodies for each molecule or for a defined subchain were used to allow tentative correlation with specific genes. Sex-dependent differences in timing and localization were found in laminin alpha 5; collagen, alpha 3, alpha 4, and alpha 5; cytokeratin 19; AMH; and SOX9. On this basis we hypothesize that the transcription factors for the mentioned structural proteins must be directly or indirectly involved in the regulatory chain of gonadal sex differentiation. Especially promising is the finding in the rat that laminin alpha 5 chain disappears from the basement membrane of embryonic testicular cords (Sertoli cells) when AMH secretion by Sertoli cells starts, and that the same chain reappears as the AMH disappears two weeks after birth. Via AMH as an intermediary factor, we now have for the first time a putative cascade of regulatory molecules from SRY, SF1, and SOX9 to a component of a structural protein (laminin alpha 5 chain) which directly participates in the formation of the basement membrane of the testicular cords. J. Exp. Zool. 290:523-528, 2001.
Subject(s)
Glycoproteins , Gonads/embryology , Proteins/physiology , Sex Differentiation/physiology , Animals , Anti-Mullerian Hormone , Collagen/physiology , Female , Gonads/chemistry , Growth Inhibitors/physiology , High Mobility Group Proteins/physiology , Laminin/chemistry , Male , Ovary/chemistry , Ovary/embryology , Rats , SOX9 Transcription Factor , Testicular Hormones/physiology , Testis/chemistry , Testis/embryology , Transcription Factors/physiologyABSTRACT
The bone morphogenetic proteins BMP-2 and BMP-4 and the homeobox gene MSX-2 are required for normal development of many embryonic tissues. To elucidate their possible roles during the remodeling of the tubular heart into a fully septated four-chambered heart, we have localized the mRNA of Bmp-2, Bmp-4, Msx-2 and apoptotic cells in the developing mouse heart from embryonic day (E)11 to E17. mRNA was localized by in situ hybridization, and apoptotic cells by TUNEL (TDT-mediated dUTP-biotin nick end-labeling) as well as by transmission electron microscopy. By analyzing adjacent serial sections, we demonstrated that the expression of Msx-2 and Bmp-2 strikingly overlapped in the atrioventricular canal myocardium, in the atrioventricular junctional myocardium, and in the maturing myocardium of the atrioventricular valves. Bmp-4 was expressed in the outflow tract myocardium and in the endocardial cushion of the outflow tract ridges from E12 to E14. Msx-2 appeared in the mesenchyme of the atrioventricular endocardial cushion from E11 to E14, while Bmp-2 and Bmp-4 were detected between E11 and E14. Apoptotic cells were also detected in the mesenchyme of the endocardial cushion between E12 and E14. Our results suggest that BMP-2 and MSX-2 are tightly linked to the formation of the atrioventricular junction and valves and that BMP-4 is involved in the development of the outflow tract myocardium and of the endocardial cushion. In addition, BMP-2, BMP-4 and MSX-2 and apoptosis seem to be associated with differentiation of the endocardial cushion.
Subject(s)
Apoptosis/physiology , Bone Morphogenetic Proteins/genetics , DNA-Binding Proteins/genetics , Endocardium/embryology , Transforming Growth Factor beta , Animals , Atrioventricular Node/embryology , Atrioventricular Node/physiology , Bone Morphogenetic Protein 2 , Bone Morphogenetic Protein 4 , Endocardium/cytology , Endocardium/physiology , Female , Gene Expression Regulation, Developmental , Heart Valves/embryology , Heart Valves/physiology , Homeodomain Proteins , In Situ Hybridization , In Situ Nick-End Labeling , Mesoderm/ultrastructure , Mice , Mice, Inbred Strains , Microscopy, Electron , Pregnancy , RNA, Messenger/analysisABSTRACT
Formation of the atrioventricular channels and valves from the endocardial cushion occurs through growth and remodeling of the initial endocardial cushion. This process requires balanced coordination of proliferation and apoptosis by still unknown factors. To detect a possible role for the heat shock proteins 25 and 70 (HSP25 and HSP70) as apoptosis-associated proteins and differentiation factors in the development of the endocardial cushion, we analyzed their temporal and regional occurrence during cell proliferation and apoptosis in E11-E17 embryos. The distribution and timing of these events and factors were consistent with the hypothesis that HSP25 is related to myocardial development whereas HSP70 is related to differentiation of the endocardial cushion by cell proliferation and apoptosis.
Subject(s)
Apoptosis/physiology , Endocardium/cytology , HSP70 Heat-Shock Proteins/analysis , Heat-Shock Proteins , Neoplasm Proteins/analysis , Animals , Endocardium/chemistry , Endocardium/embryology , Female , Mesoderm/cytology , Mice , Mice, Inbred Strains , Microscopy, Electron , Mitosis/physiology , Molecular Chaperones , Muscle Fibers, Skeletal/chemistry , Muscle Fibers, Skeletal/ultrastructure , Pregnancy , Proliferating Cell Nuclear Antigen/analysisABSTRACT
OBJECTIVE: In rheumatoid arthritis (RA) the synovial lining is responsible for cartilage destruction. Laminin is one of the major matrix molecules surrounding the lining cells. We investigated the laminin adhesion mechanism of synovial lining cells by analyzing the presence of its receptor, alpha6beta1 integrin, on type A and type B synoviocytes. METHODS: The alpha6 integrin subunit and a macrophage marker were simultaneously localized by immunohistochemistry in 29 RA derived, 6 osteoarthritis derived, and 2 healthy synovial samples by light and electron microscopy. We also used enzyme treatments to release cells from synovial tissue samples and localized the same antigens on adherent cells. RESULTS: The alpha6beta1 integrin positive cells were localized in basal areas of the lining layer and many of them were negative for the macrophage markers. By immunolabeling electron microscopy the alpha6 integrin positive cells were confirmed to represent the fibroblast-like type B cells. Further, in freshly isolated synoviocyte cultures the type B cells were positive for alpha6 integrin, whereas all other cell types were negative for this laminin receptor. CONCLUSION: Integrin alpha6beta1 is known to be a laminin receptor of endothelial cells, adipocytes, and macrophages, not usually expressed on fibroblasts. However, in synovial lining layer it is expressed on fibroblastic type B cells, but the macrophage population is negative. The unique characteristics of synovial lining cells distinguish them from other connective tissue cells and must be taken into account in all considerations of the pathogenic mechanisms of rheumatoid disease.
Subject(s)
Arthritis, Rheumatoid/pathology , Integrins/analysis , Synovial Membrane/chemistry , Synovial Membrane/cytology , Arthritis, Rheumatoid/immunology , CD18 Antigens/analysis , Cell Membrane/chemistry , Cell Membrane/ultrastructure , Fibroblasts/chemistry , Fibroblasts/ultrastructure , Humans , Integrin alpha6beta1 , Lipopolysaccharide Receptors/analysis , Macrophages/chemistry , Microscopy, Electron , Middle Aged , Synovial Membrane/immunologyABSTRACT
OBJECTIVE: This study investigated the outcome of testicular cancer treatment in Finland. MATERIAL AND METHODS: Data on 88 testicular cancer patients treated in Turku University Central Hospital between 1976 and 1992 were studied to analyse outcome and survival. RESULTS: The histological diagnosis was seminoma for 39 patients and non-seminoma for 49 patients. Two seminoma patients relapsed (5%) and one patient died of progressive disease (3%; initially stage II seminoma). Eleven non-seminoma patients relapsed (22%), nine of whom were cured with chemotherapy. Four non-seminoma patients died of progressive disease (8%; initially one stage I non-seminoma and three stage III non-seminomas). The median time to relapse after the completion of treatment was 9 months (range 3-50 months). Non-seminoma patients had significantly more relapses than seminoma patients (p = 0.03). Most relapses (73% of the non-seminoma relapses) were found among the stage I non-seminoma patients who had not received adjuvant chemotherapy, while none of the stage I seminoma patients relapsed (p = 0.007). CONCLUSIONS: Close surveillance is important for all non-seminoma patients to guarantee the early detection and treatment of recurrent disease. Treatment and surveillance should be covered by national guidelines and be conducted in centres with special interest in this rare but mostly curable cancer.
Subject(s)
Carcinoma/pathology , Carcinoma/therapy , Seminoma/pathology , Seminoma/therapy , Testicular Neoplasms/pathology , Testicular Neoplasms/therapy , Adolescent , Adult , Carcinoma/mortality , Chemotherapy, Adjuvant , Combined Modality Therapy , Disease-Free Survival , Finland/epidemiology , Follow-Up Studies , Humans , Male , Middle Aged , Orchiectomy/methods , Probability , Radiotherapy, Adjuvant , Retrospective Studies , Seminoma/mortality , Survival Rate , Testicular Neoplasms/mortality , Treatment OutcomeABSTRACT
Although the presence of 'cartilage-specific' collagens in the eye has been documented earlier, very little is known about their synthesis rates during ocular development, growth and aging. The purpose of the present study was to follow changes in the mRNA levels and distribution of key components of the extracellular matrix in the eyes of normal and transgenic Del1 mice, harboring a short deletion mutation in the type II collagen gene, during ocular growth and aging. Total RNAs extracted from mouse eyes were studied by Northern analysis for mRNA levels of type I, II, III, VI, IX and XI collagens, biglycan, fibromodulin and decorin. A predominant finding of the present study was the marked reduction in the mRNA levels of type I and II collagens in the eye upon aging. The changes in the mRNA levels of type III and VI collagen and proteoglycans were smaller. Localization of type II and IX collagen in the eye was performed by immunohistochemistry. Despite the reduction in the type II collagen mRNA levels, immunohistochemistry confirmed widespread distribution of the protein also in aging mouse eyes, suggesting its slow turnover. Although the Del1 mutation caused gradual degenerative lesions in the eyes, the distribution of the protein remained essentially unchanged. The widespread distribution and marked downregulation of type II collagen production in the mouse eye upon aging probably explain the gradual development of degenerative lesions, particularly in the eyes of transgenic Del1 mice, where production of mutant type II collagen chains also contributes to the process.
Subject(s)
Aging/physiology , Extracellular Matrix Proteins/metabolism , Eye/metabolism , Animals , Biglycan , Blotting, Northern , Carrier Proteins/metabolism , Chromatography, Ion Exchange , Collagen/genetics , Decorin , Down-Regulation , Fibromodulin , Gene Deletion , Gene Expression , Mice , Mice, Transgenic , Proteoglycans/metabolism , RNA, MessengerABSTRACT
To study the effects of etoposide on experimental testicular teratoma in 129/SvJ mouse we analysed the tumour growth, differentiation, apoptosis and the localisation of mdr1 P-glycoprotein (mdr1-Pgp). In this model the implanted gonadal ridges developed into testicular teratomas in 17 out of 56 implanted testes (30%) and in 14 out of 28 mice (50%). The tumour-bearing mice were treated with etoposide on 4 successive days either 4 weeks or 6 weeks after implantation, and killed 7 days after the last dose. The mice in the control groups did not receive etoposide. The teratomas consisted mainly of neural tissue. The etoposide-treated 4-week teratomas, but not the 6-week teratomas, were significantly smaller than those in the corresponding control groups. The density of apoptotic cells and the distribution of the mdr1-Pgp were not altered by etoposide. The decreased proportion of immature neuroectodermal tissue components was observed in all treated teratomas, converting the histology towards that of a mature teratoma. In addition, a low proportion of immature tissue components was frequently combined with a low density of apoptotic cells. In conclusion, etoposide decreased the immature tissue components of teratomas, while mature tissues remained unaffected. These results may have clinical relevance in man, since they confirm that postchemotherapy mature teratomas cannot be treated with chemotherapy. Despite benign histology, the human residual tumours have a significant malignant potential and require complete surgical excision and close surveillance.
Subject(s)
Antineoplastic Agents, Phytogenic/therapeutic use , Etoposide/therapeutic use , Teratoma/drug therapy , Testicular Neoplasms/drug therapy , ATP Binding Cassette Transporter, Subfamily B, Member 1/analysis , Animals , Apoptosis , DNA Fragmentation , Disease Models, Animal , Drug Resistance , Immunohistochemistry , Injections, Intraperitoneal , Male , Mice , Mice, Inbred Strains , Teratoma/pathology , Teratoma/surgery , Testicular Neoplasms/pathology , Testicular Neoplasms/surgeryABSTRACT
We studied the location of Sox9 protein in the embryonic, juvenile, and adult rat testis by immunohistochemistry and immunoblotting. Sox9 belongs to a family of Sox proteins that are transcription factors and important in several developmental processes. In the incipient embryonic testis, Sox9 was prominently present in the gonadal blastema. With further embryonic differentiation, Sox9-positive cells arranged in the periphery of the testicular cords, showing the location of the Sertoli cells. Thereafter the immunoreaction for Sox9 gradually declined and was only weakly detectable in the 2-day-old postnatal rat testis. This situation remained for some period of time. In the 15-day-old rat testis, Sox9 protein strongly reappeared in the testicular cords. In the adult, the Sertoli cells of most regions of the seminiferous tubules were positive for Sox9. The strongest reaction for Sox9 was found in the dark zone. However, clearly negative or only weakly positive spermatogenic stages for the protein were also found, as seen for example in the pale zone. In fertile 1-year-old rats this basic situation was still detectable. Analyzed rat ovaries were all negative for Sox9, showing the sex-specific nature of Sox9. The results showed that Sox9 protein is distinctly present in the developing and mature Sertoli cells, but that its presence and amount is dependent on the age and the spermatogenetic stage within the seminiferous tubuli. The prominent presence of Sox9 in the incipient testis and at puberty suggests that this protein is needed at important phases of aggregation and reorganization of the Sertoli cells. The age and stage-specific presence of Sox9 in the testicular cords and in the seminiferous tubules of the adult suggests that Sox9 also may have a pivotal role in germ cell differentiation.